Synthesis, Antimicrobial, and In silico Studies of 2-Hydroxy-1,
| dc.contributor.advisor | Daniel Bisrat | |
| dc.contributor.author | Temesgen Kusse | |
| dc.date.accessioned | 2026-06-22T15:50:12Z | |
| dc.date.available | 2026-06-22T15:50:12Z | |
| dc.date.issued | 2025-06-10 | |
| dc.description.abstract | Infectious diseases place a significant impact on the healthcare system. It causes 7.7 million fatalities each year, with a disproportionately high burden in sub-Saharan Africa. Drug resistant pathogens attributed to 4.95 million are and 1.27 million are brought on by illnesses of bacteria that are resistant to the current medications. Therefore, there is an urgent need for new, safe, and effective compounds to combat antimicrobial resistance (AMR). In | |
| dc.identifier.uri | https://etd.aau.edu.et/handle/123456789/8407 | |
| dc.language.iso | en_US | |
| dc.publisher | Addis Ababa University | |
| dc.subject | 2-Hydroxy-1 | |
| dc.subject | 2-diphenylethanone | |
| dc.subject | Antimicrobial activity | |
| dc.subject | In-silico studies | |
| dc.subject | Disulfide bond oxidoreductase (DsbA) | |
| dc.subject | Mannich reaction | |
| dc.title | Synthesis, Antimicrobial, and In silico Studies of 2-Hydroxy-1, | |
| dc.type | Thesis |